Histopathological findings obtained from reduction mammoplasty specimens

Area of Science:

• Pathology
• Surgical Oncology
• Breast Health

Background:

• Reduction mammoplasty is a frequent surgical procedure.
• Histopathological analysis of breast reduction specimens is crucial for understanding breast lesion prevalence.
• Limited data exists on lesion rates in reduction mammoplasty, particularly in specific populations.

Purpose of the Study:

• To determine the incidence of nonproliferative and proliferative breast lesions in reduction mammoplasty specimens.
• To investigate the prevalence of columnar cell lesions with and without atypia in this patient cohort.
• To assess the clinical significance of these findings for breast cancer screening strategies.

Main Methods:

• Retrospective analysis of histopathology reports from reduction mammoplasty procedures over a 6-year period (2004-2010).
• Recording and evaluation of clinical and histopathological findings for 106 patients.
• Categorization of identified breast lesions, including proliferative, nonproliferative, and columnar cell lesions.

Main Results:

• A significant proportion of patients (52.8%) exhibited proliferative breast lesions and (79.2%) nonproliferative lesions.
• Columnar cell lesions were prevalent, with 57.5% showing atypia and 7.5% without atypia.
• No invasive breast cancer was detected in the analyzed specimens, but 5.6% had lobular carcinoma in situ.

Conclusions:

• Histopathological analysis of reduction mammoplasty specimens is essential for identifying breast lesions.
• Elevated rates of columnar cell lesions, particularly with atypia, underscore the need for vigilant screening.
• Findings suggest a potential need for earlier breast cancer screening in younger patients undergoing reduction mammoplasty, especially in regions with high breast cancer incidence.